Index by author

01 May 2004; volume 23, issue 5

A

  1. Abramowicz, M.

    1. Abramowicz, M., and M. Delcroix. "From the Authors." European Respiratory Journal 23.5 (2004): 790-791. Web. 21 June. 2021.

  2. Alexopoulos, E.I.

    1. Kostadima, E. et al "Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma." European Respiratory Journal 23.5 (2004): 714-717. Web. 21 June. 2021.

  3. Anees, W.

    1. Anees, W. et al "Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma." European Respiratory Journal 23.5 (2004): 730-734. Web. 21 June. 2021.

  4. Anthonisen, N.R.

    1. Anthonisen, N.R.. "The British hypothesis revisited." European Respiratory Journal 23.5 (2004): 657-658. Web. 21 June. 2021.

  5. Antonicelli, L.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.

  6. Asano, K.

    1. Kanai, K. et al "Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro." European Respiratory Journal 23.5 (2004): 671-678. Web. 21 June. 2021.

B

  1. Bailey, M.

    1. Roebuck, T. et al "Increased long-term mortality in heart failure due to sleep apnoea is not yet proven." European Respiratory Journal 23.5 (2004): 735-740. Web. 21 June. 2021.

  2. Banerjee, D.

    1. Banerjee, D., O.A. Khair, and D. Honeybourne. "Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD." European Respiratory Journal 23.5 (2004): 685-691. Web. 21 June. 2021.

  3. Becker, H.F.

    1. Becker, H.F.. "Bigger numbers needed!." European Respiratory Journal 23.5 (2004): 659-660. Web. 21 June. 2021.

  4. Bergin, P.

    1. Roebuck, T. et al "Increased long-term mortality in heart failure due to sleep apnoea is not yet proven." European Respiratory Journal 23.5 (2004): 735-740. Web. 21 June. 2021.

  5. Bonifazi, F.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.

  6. Brambilla, E.

    1. Eymin, B., and E. Brambilla. "The yin and the yang of p27Kip1 as a target for cancer therapy." European Respiratory Journal 23.5 (2004): 663-664. Web. 21 June. 2021.

  7. Bucca, C.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.

  8. Buehling, F.

    1. Waldburg, N. et al "Pulmonary infiltrates in Costello Syndrome." European Respiratory Journal 23.5 (2004): 783-785. Web. 21 June. 2021.

  9. Burge, P.S.

    1. Spencer, S. et al "Impact of preventing exacerbations on deterioration of health status in COPD." European Respiratory Journal 23.5 (2004): 698-702. Web. 21 June. 2021.
    2. Anees, W. et al "Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma." European Respiratory Journal 23.5 (2004): 730-734. Web. 21 June. 2021.

  10. Burkhardt, O.

    1. Waldburg, N. et al "Pulmonary infiltrates in Costello Syndrome." European Respiratory Journal 23.5 (2004): 783-785. Web. 21 June. 2021.

C

  1. Calverley, P.M.A.

    1. Spencer, S. et al "Impact of preventing exacerbations on deterioration of health status in COPD." European Respiratory Journal 23.5 (2004): 698-702. Web. 21 June. 2021.

  2. Castellani, C.

    1. Decaestecker, K. et al "Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients." European Respiratory Journal 23.5 (2004): 679-684. Web. 21 June. 2021.

  3. Cavazza, A.

    1. Dallari, R. et al "Acute exacerbation of idiopathic pulmonary fibrosis." European Respiratory Journal 23.5 (2004): 792. Web. 21 June. 2021.

  4. Criée, C.P.

    1. Windisch, W. et al "Peak or plateau maximal inspiratory mouth pressure: which is best?." European Respiratory Journal 23.5 (2004): 708-713. Web. 21 June. 2021.

  5. Cuppens, H.

    1. Decaestecker, K. et al "Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients." European Respiratory Journal 23.5 (2004): 679-684. Web. 21 June. 2021.

D

  1. Dallari, R.

    1. Dallari, R. et al "Acute exacerbation of idiopathic pulmonary fibrosis." European Respiratory Journal 23.5 (2004): 792. Web. 21 June. 2021.

  2. De Benedetto, F.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.

  3. Deboeck, G.

    1. Deboeck, G. et al "Exercise testing in pulmonary arterial hypertension and in chronic heart failure." European Respiratory Journal 23.5 (2004): 747-751. Web. 21 June. 2021.

  4. De Boeck, K.

    1. Decaestecker, K. et al "Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients." European Respiratory Journal 23.5 (2004): 679-684. Web. 21 June. 2021.

  5. De Boosere, E.

    1. De Weerdt, S. et al "Cough, fatigue and fever." European Respiratory Journal 23.5 (2004): 786-789. Web. 21 June. 2021.

  6. Decaestecker, E.

    1. Decaestecker, K. et al "Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients." European Respiratory Journal 23.5 (2004): 679-684. Web. 21 June. 2021.

  7. Decaestecker, K.

    1. Decaestecker, K. et al "Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients." European Respiratory Journal 23.5 (2004): 679-684. Web. 21 June. 2021.

  8. Delcroix, M.

    1. Abramowicz, M., and M. Delcroix. "From the Authors." European Respiratory Journal 23.5 (2004): 790-791. Web. 21 June. 2021.

  9. Delp, M.D.

    1. Mattson, J.P., M.D. Delp, and D.C. Poole. "Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters." European Respiratory Journal 23.5 (2004): 703-707. Web. 21 June. 2021.

  10. de Melo, M.N.

    1. de Melo, M.N., P. Ernst, and S. Suissa. "Inhaled corticosteroids and the risk of a first exacerbation in COPD patients." European Respiratory Journal 23.5 (2004): 692-697. Web. 21 June. 2021.

  11. de Montpreville, V.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

  12. Denig, P.

    1. Pont, L.G. et al "Relationship between guideline treatment and health-related quality of life in asthma." European Respiratory Journal 23.5 (2004): 718-722. Web. 21 June. 2021.

  13. De Weerdt, S.

    1. De Weerdt, S. et al "Cough, fatigue and fever." European Respiratory Journal 23.5 (2004): 786-789. Web. 21 June. 2021.

  14. De Wever, W.

    1. De Wever, W. et al "Multidetector CT-generated virtual bronchoscopy: an illustrated review of the potential clinical indications." European Respiratory Journal 23.5 (2004): 776-782. Web. 21 June. 2021.

  15. Dinh-Xuan, A.T.

    1. Dinh-Xuan, A.T., and R. Naeije. "The hepatopulmonary syndrome: NO way out?." European Respiratory Journal 23.5 (2004): 661-662. Web. 21 June. 2021.

  16. Di Sacco, G.

    1. Di Sacco, G.. "Amfepramone does not cause primary pulmonary hypertension." European Respiratory Journal 23.5 (2004): 790. Web. 21 June. 2021.

E

  1. Eichler, H‐G.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.

  2. Ernst, P.

    1. de Melo, M.N., P. Ernst, and S. Suissa. "Inhaled corticosteroids and the risk of a first exacerbation in COPD patients." European Respiratory Journal 23.5 (2004): 692-697. Web. 21 June. 2021.

  3. Evert, M.

    1. Waldburg, N. et al "Pulmonary infiltrates in Costello Syndrome." European Respiratory Journal 23.5 (2004): 783-785. Web. 21 June. 2021.

  4. Eymin, B.

    1. Eymin, B., and E. Brambilla. "The yin and the yang of p27Kip1 as a target for cancer therapy." European Respiratory Journal 23.5 (2004): 663-664. Web. 21 June. 2021.

F

  1. Fakes, K.

    1. Simpson, J.L. et al "Effect of saliva contamination on induced sputum cell counts, IL‐8 and eosinophil cationic protein levels." European Respiratory Journal 23.5 (2004): 759-762. Web. 21 June. 2021.

  2. Foglia, M.

    1. Dallari, R. et al "Acute exacerbation of idiopathic pulmonary fibrosis." European Respiratory Journal 23.5 (2004): 792. Web. 21 June. 2021.

  3. Fujishiro, M.

    1. Ishii, T. et al "Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells." European Respiratory Journal 23.5 (2004): 665-670. Web. 21 June. 2021.

G

  1. Gannon, P.F.

    1. Anees, W. et al "Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma." European Respiratory Journal 23.5 (2004): 730-734. Web. 21 June. 2021.

  2. Georgatou, N.

    1. Kostadima, E. et al "Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma." European Respiratory Journal 23.5 (2004): 714-717. Web. 21 June. 2021.

  3. Gibson, P.G.

    1. Simpson, J.L. et al "Effect of saliva contamination on induced sputum cell counts, IL‐8 and eosinophil cationic protein levels." European Respiratory Journal 23.5 (2004): 759-762. Web. 21 June. 2021.

  4. Goossens, A.

    1. De Weerdt, S. et al "Cough, fatigue and fever." European Respiratory Journal 23.5 (2004): 786-789. Web. 21 June. 2021.

  5. Goshima, Y.

    1. Ishii, T. et al "Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells." European Respiratory Journal 23.5 (2004): 665-670. Web. 21 June. 2021.

H

  1. Haaijer-Ruskamp, F.M.

    1. Pont, L.G. et al "Relationship between guideline treatment and health-related quality of life in asthma." European Respiratory Journal 23.5 (2004): 718-722. Web. 21 June. 2021.

  2. Hamm, H.

    1. Windisch, W. et al "Peak or plateau maximal inspiratory mouth pressure: which is best?." European Respiratory Journal 23.5 (2004): 708-713. Web. 21 June. 2021.

  3. Hennings, E.

    1. Windisch, W. et al "Peak or plateau maximal inspiratory mouth pressure: which is best?." European Respiratory Journal 23.5 (2004): 708-713. Web. 21 June. 2021.

  4. Henry, M.T.

    1. Henry, M.T. et al "Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response." European Respiratory Journal 23.5 (2004): 741-746. Web. 21 June. 2021.

  5. Hervé, P.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

  6. Hisamitsu, T.

    1. Kanai, K. et al "Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro." European Respiratory Journal 23.5 (2004): 671-678. Web. 21 June. 2021.

  7. Hogg, J.C.

    1. Newell, J.D., J.C. Hogg, and G.L. Snider. "Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema." European Respiratory Journal 23.5 (2004): 769-775. Web. 21 June. 2021.

  8. Honeybourne, D.

    1. Banerjee, D., O.A. Khair, and D. Honeybourne. "Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD." European Respiratory Journal 23.5 (2004): 685-691. Web. 21 June. 2021.

  9. Huggins, V.

    1. Anees, W. et al "Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma." European Respiratory Journal 23.5 (2004): 730-734. Web. 21 June. 2021.

  10. Hülskamp, G.

    1. Pillow, J.J. et al "Functional residual capacity measurements in healthy infants: ultrasonic flow meter versus a mass spectrometer." European Respiratory Journal 23.5 (2004): 763-768. Web. 21 June. 2021.

  11. Humbert, M.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

I

  1. Inamdar, L.

    1. Henry, M.T. et al "Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response." European Respiratory Journal 23.5 (2004): 741-746. Web. 21 June. 2021.

  2. Ishii, T.

    1. Ishii, T. et al "Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells." European Respiratory Journal 23.5 (2004): 665-670. Web. 21 June. 2021.

J

  1. Jaspers, M.

    1. Decaestecker, K. et al "Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients." European Respiratory Journal 23.5 (2004): 679-684. Web. 21 June. 2021.

  2. Jones, P.W.

    1. Spencer, S. et al "Impact of preventing exacerbations on deterioration of health status in COPD." European Respiratory Journal 23.5 (2004): 698-702. Web. 21 June. 2021.

K

  1. Kaditis, A.G.

    1. Kostadima, E. et al "Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma." European Respiratory Journal 23.5 (2004): 714-717. Web. 21 June. 2021.

  2. Kanai, K.

    1. Kanai, K. et al "Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro." European Respiratory Journal 23.5 (2004): 671-678. Web. 21 June. 2021.

  3. Kaye, D.M.

    1. Roebuck, T. et al "Increased long-term mortality in heart failure due to sleep apnoea is not yet proven." European Respiratory Journal 23.5 (2004): 735-740. Web. 21 June. 2021.

  4. Khair, O.A.

    1. Banerjee, D., O.A. Khair, and D. Honeybourne. "Impact of sputum bacteria on airway inflammation and health status in clinical stable COPD." European Respiratory Journal 23.5 (2004): 685-691. Web. 21 June. 2021.

  5. Kitamura, H.

    1. Ishii, T. et al "Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells." European Respiratory Journal 23.5 (2004): 665-670. Web. 21 June. 2021.

  6. Kostadima, E.

    1. Kostadima, E. et al "Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma." European Respiratory Journal 23.5 (2004): 714-717. Web. 21 June. 2021.

L

  1. Lamotte, M.

    1. Deboeck, G. et al "Exercise testing in pulmonary arterial hypertension and in chronic heart failure." European Respiratory Journal 23.5 (2004): 747-751. Web. 21 June. 2021.

  2. Lanciotti, S.

    1. De Wever, W. et al "Multidetector CT-generated virtual bronchoscopy: an illustrated review of the potential clinical indications." European Respiratory Journal 23.5 (2004): 776-782. Web. 21 June. 2021.

  3. Lebrec, D.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

  4. Le Pape, A.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

  5. Ljungberg, H.

    1. Pillow, J.J. et al "Functional residual capacity measurements in healthy infants: ultrasonic flow meter versus a mass spectrometer." European Respiratory Journal 23.5 (2004): 763-768. Web. 21 June. 2021.

M

  1. Masuda, M.

    1. Ishii, T. et al "Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells." European Respiratory Journal 23.5 (2004): 665-670. Web. 21 June. 2021.

  2. Matsuse, T.

    1. Ishii, T. et al "Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells." European Respiratory Journal 23.5 (2004): 665-670. Web. 21 June. 2021.

  3. Mattson, J.P.

    1. Mattson, J.P., M.D. Delp, and D.C. Poole. "Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters." European Respiratory Journal 23.5 (2004): 703-707. Web. 21 June. 2021.

  4. Mavrou, I.

    1. Kostadima, E. et al "Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma." European Respiratory Journal 23.5 (2004): 714-717. Web. 21 June. 2021.

  5. Mazmanian, M.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

  6. Meysman, M.

    1. De Weerdt, S. et al "Cough, fatigue and fever." European Respiratory Journal 23.5 (2004): 786-789. Web. 21 June. 2021.

N

  1. Naeije, R.

    1. Dinh-Xuan, A.T., and R. Naeije. "The hepatopulmonary syndrome: NO way out?." European Respiratory Journal 23.5 (2004): 661-662. Web. 21 June. 2021.
    2. Deboeck, G. et al "Exercise testing in pulmonary arterial hypertension and in chronic heart failure." European Respiratory Journal 23.5 (2004): 747-751. Web. 21 June. 2021.

  2. Naughton, M.T.

    1. Roebuck, T. et al "Increased long-term mortality in heart failure due to sleep apnoea is not yet proven." European Respiratory Journal 23.5 (2004): 735-740. Web. 21 June. 2021.

  3. Neri, M.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.

  4. Newell, J.D.

    1. Newell, J.D., J.C. Hogg, and G.L. Snider. "Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema." European Respiratory Journal 23.5 (2004): 769-775. Web. 21 June. 2021.

  5. Niset, G.

    1. Deboeck, G. et al "Exercise testing in pulmonary arterial hypertension and in chronic heart failure." European Respiratory Journal 23.5 (2004): 747-751. Web. 21 June. 2021.

  6. Noppen, M.

    1. De Weerdt, S. et al "Cough, fatigue and fever." European Respiratory Journal 23.5 (2004): 786-789. Web. 21 June. 2021.

  7. Nunes, H.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

O

  1. O'Driscoll, R.

    1. O'Driscoll, R.. "Declaration of conflicts of interest." European Respiratory Journal 23.5 (2004): 791. Web. 21 June. 2021.

  2. O'Riordain, D.

    1. Henry, M.T. et al "Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response." European Respiratory Journal 23.5 (2004): 741-746. Web. 21 June. 2021.

P

  1. Paci, M.

    1. Dallari, R. et al "Acute exacerbation of idiopathic pulmonary fibrosis." European Respiratory Journal 23.5 (2004): 792. Web. 21 June. 2021.

  2. Pantin, C.F.A.

    1. Anees, W. et al "Effect of peak expiratory flow data quantity on diagnostic sensitivity and specificity in occupational asthma." European Respiratory Journal 23.5 (2004): 730-734. Web. 21 June. 2021.

  3. Papamichalopoulos, A.

    1. Kostadima, E. et al "Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma." European Respiratory Journal 23.5 (2004): 714-717. Web. 21 June. 2021.

  4. Pillow, J.J.

    1. Pillow, J.J. et al "Functional residual capacity measurements in healthy infants: ultrasonic flow meter versus a mass spectrometer." European Respiratory Journal 23.5 (2004): 763-768. Web. 21 June. 2021.

  5. Pletinckx, A.

    1. De Weerdt, S. et al "Cough, fatigue and fever." European Respiratory Journal 23.5 (2004): 786-789. Web. 21 June. 2021.

  6. Pont, L.G.

    1. Pont, L.G. et al "Relationship between guideline treatment and health-related quality of life in asthma." European Respiratory Journal 23.5 (2004): 718-722. Web. 21 June. 2021.

  7. Poole, D.C.

    1. Mattson, J.P., M.D. Delp, and D.C. Poole. "Differential effects of emphysema on skeletal muscle fibre atrophy in hamsters." European Respiratory Journal 23.5 (2004): 703-707. Web. 21 June. 2021.

R

  1. Rabe, K.F.

    1. Rabe, K.F., and P.J. Sterk. "From the Editors." European Respiratory Journal 23.5 (2004): 791. Web. 21 June. 2021.

  2. Rabiller, A.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

  3. Remels, L.

    1. De Weerdt, S. et al "Cough, fatigue and fever." European Respiratory Journal 23.5 (2004): 786-789. Web. 21 June. 2021.

  4. Roebuck, T.

    1. Roebuck, T. et al "Increased long-term mortality in heart failure due to sleep apnoea is not yet proven." European Respiratory Journal 23.5 (2004): 735-740. Web. 21 June. 2021.

S

  1. Sabbatani, P.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.

  2. Savale, L.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

  3. Schweiger, M.

    1. Henry, M.T. et al "Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response." European Respiratory Journal 23.5 (2004): 741-746. Web. 21 June. 2021.

  4. Simpson, J.L.

    1. Simpson, J.L. et al "Effect of saliva contamination on induced sputum cell counts, IL‐8 and eosinophil cationic protein levels." European Respiratory Journal 23.5 (2004): 759-762. Web. 21 June. 2021.

  5. Snider, G.L.

    1. Newell, J.D., J.C. Hogg, and G.L. Snider. "Report of a workshop: quantitative computed tomography scanning in longitudinal studies of emphysema." European Respiratory Journal 23.5 (2004): 769-775. Web. 21 June. 2021.

  6. Solin, P.

    1. Roebuck, T. et al "Increased long-term mortality in heart failure due to sleep apnoea is not yet proven." European Respiratory Journal 23.5 (2004): 735-740. Web. 21 June. 2021.

  7. Sorichter, S.

    1. Windisch, W. et al "Peak or plateau maximal inspiratory mouth pressure: which is best?." European Respiratory Journal 23.5 (2004): 708-713. Web. 21 June. 2021.

  8. Spencer, S.

    1. Spencer, S. et al "Impact of preventing exacerbations on deterioration of health status in COPD." European Respiratory Journal 23.5 (2004): 698-702. Web. 21 June. 2021.

  9. Sterk, P.J.

    1. Rabe, K.F., and P.J. Sterk. "From the Editors." European Respiratory Journal 23.5 (2004): 791. Web. 21 June. 2021.

  10. Stocks, J.

    1. Pillow, J.J. et al "Functional residual capacity measurements in healthy infants: ultrasonic flow meter versus a mass spectrometer." European Respiratory Journal 23.5 (2004): 763-768. Web. 21 June. 2021.

  11. Suissa, S.

    1. de Melo, M.N., P. Ernst, and S. Suissa. "Inhaled corticosteroids and the risk of a first exacerbation in COPD patients." European Respiratory Journal 23.5 (2004): 692-697. Web. 21 June. 2021.

  12. Suzaki, H.

    1. Kanai, K. et al "Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro." European Respiratory Journal 23.5 (2004): 671-678. Web. 21 June. 2021.

  13. Sztrymf, B.

    1. Sztrymf, B. et al "Prevention of hepatopulmonary syndrome and hyperdynamic state by pentoxifylline in cirrhotic rats." European Respiratory Journal 23.5 (2004): 752-758. Web. 21 June. 2021.

T

  1. Talbot, P.I.

    1. Simpson, J.L. et al "Effect of saliva contamination on induced sputum cell counts, IL‐8 and eosinophil cationic protein levels." European Respiratory Journal 23.5 (2004): 759-762. Web. 21 June. 2021.

  2. Teramoto, S.

    1. Ishii, T. et al "Effects of p27Kip1 on cell cycle status and viability in A549 lung adenocarcinoma cells." European Respiratory Journal 23.5 (2004): 665-670. Web. 21 June. 2021.

  3. Timmins, N.L.

    1. Simpson, J.L. et al "Effect of saliva contamination on induced sputum cell counts, IL‐8 and eosinophil cationic protein levels." European Respiratory Journal 23.5 (2004): 759-762. Web. 21 June. 2021.

  4. Tsiodras, S.

    1. Kostadima, E. et al "Clarithromycin reduces the severity of bronchial hyperresponsiveness in patients with asthma." European Respiratory Journal 23.5 (2004): 714-717. Web. 21 June. 2021.

V

  1. Vachiéry, J‐L.

    1. Deboeck, G. et al "Exercise testing in pulmonary arterial hypertension and in chronic heart failure." European Respiratory Journal 23.5 (2004): 747-751. Web. 21 June. 2021.

  2. Vandecaveye, V.

    1. De Wever, W. et al "Multidetector CT-generated virtual bronchoscopy: an illustrated review of the potential clinical indications." European Respiratory Journal 23.5 (2004): 776-782. Web. 21 June. 2021.

  3. van der Molen, T.

    1. Pont, L.G. et al "Relationship between guideline treatment and health-related quality of life in asthma." European Respiratory Journal 23.5 (2004): 718-722. Web. 21 June. 2021.

  4. van der Werf, G.T.

    1. Pont, L.G. et al "Relationship between guideline treatment and health-related quality of life in asthma." European Respiratory Journal 23.5 (2004): 718-722. Web. 21 June. 2021.

  5. Verschakelen, J.A.

    1. De Wever, W. et al "Multidetector CT-generated virtual bronchoscopy: an illustrated review of the potential clinical indications." European Respiratory Journal 23.5 (2004): 776-782. Web. 21 June. 2021.

  6. Vincken, W.

    1. De Weerdt, S. et al "Cough, fatigue and fever." European Respiratory Journal 23.5 (2004): 786-789. Web. 21 June. 2021.

W

  1. Waldburg, N.

    1. Waldburg, N. et al "Pulmonary infiltrates in Costello Syndrome." European Respiratory Journal 23.5 (2004): 783-785. Web. 21 June. 2021.

  2. Watson, J.P.

    1. Henry, M.T. et al "Nontuberculous mycobacteria in non‐HIV patients: epidemiology, treatment and response." European Respiratory Journal 23.5 (2004): 741-746. Web. 21 June. 2021.

  3. Welte, T.

    1. Waldburg, N. et al "Pulmonary infiltrates in Costello Syndrome." European Respiratory Journal 23.5 (2004): 783-785. Web. 21 June. 2021.

  4. Windisch, W.

    1. Windisch, W. et al "Peak or plateau maximal inspiratory mouth pressure: which is best?." European Respiratory Journal 23.5 (2004): 708-713. Web. 21 June. 2021.

Y

  1. Yin, D.D.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.

Z

  1. Zhang, Q.

    1. Antonicelli, L. et al "Asthma severity and medical resource utilisation." European Respiratory Journal 23.5 (2004): 723-729. Web. 21 June. 2021.
Back to top

Search Within This Issue

Jump to

Manage Table of content Alerts